Compare CORT & CACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | CACI |
|---|---|---|
| Founded | 1998 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 12.9B |
| IPO Year | N/A | 1979 |
| Metric | CORT | CACI |
|---|---|---|
| Price | $88.23 | $572.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $139.00 | ★ $616.50 |
| AVG Volume (30 Days) | ★ 690.9K | 236.7K |
| Earning Date | 11-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.06 |
| EPS | 0.87 | ★ 22.62 |
| Revenue | $741,172,000.00 | ★ $8,858,558,000.00 |
| Revenue This Year | $23.79 | $10.71 |
| Revenue Next Year | $40.97 | $6.15 |
| P/E Ratio | $100.74 | ★ $25.30 |
| Revenue Growth | ★ 17.92 | 12.61 |
| 52 Week Low | $49.00 | $318.60 |
| 52 Week High | $117.33 | $632.77 |
| Indicator | CORT | CACI |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 41.70 |
| Support Level | $81.31 | $583.84 |
| Resistance Level | $87.19 | $603.75 |
| Average True Range (ATR) | 2.86 | 17.73 |
| MACD | 0.74 | -5.57 |
| Stochastic Oscillator | 93.81 | 0.92 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.